Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Smartkem to Participate at the PlayNitride 2025 MicroLED Technology Forum and Exhibit at SEMICON® Taiwan 2025
-
RetailPro, a Nayax Company, and Onebeat Partner to Transform Inventory from Static Data to Real-Time Profit Engine
-
e-STORAGE Launches FlexBank 1.0, an 8.36 MWh Energy Storage Modular Battery, at RE+ 2025 in Las Vegas
-
Agios Provides Update on U.S. PDUFA Goal Date for PYRUKYND® (mitapivat) in Thalassemia
-
Creator Television® Expands Tentpole Creators Roster
-
Sola Security raises $35M A round to pioneer AI in cybersecurity
-
Ciena Reports Fiscal Third Quarter 2025 Financial Results
-
8th Annual United Way of Stephens County Barbecue Showdown Set for September 12-13 at Fuqua Park
-
Syantra, Inc., announces new therapeutic division for immuno-oncology drug discovery, leveraging its patent-pending Onco-ID™ platform
-
Skye’s CB1 Inhibitor, Nimacimab, Demonstrates Superior Weight Loss and Differentiated Mechanisms from Monlunabant, and Continues to Show Enhanced Combination with Tirzepatide with Durable Post-Trea
-
TappAlpha Expands ETF Lineup with the Innovation 100 Growth & Daily Income ETF (TDAQ)
-
Despite 7 in 8 Ecommerce Brands Raising Prices to Offset Tariffs, 96% Still Expect International Sales to Rise in Q4
-
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Recall.ai Closes $38M Series B Funding to Power the AI Stack for Conversation Data
-
Nusano Announces September Conference Schedule
-
Sentec Receives FDA Clearance for LuMon™ Electrical Impedance Tomography (EIT) System -- First EIT System Indicated for Premature Infants and for Spontaneously Breathing Patients in the United State
-
Orbital Therapeutics Appoints Accomplished Drug Developer Adam Raff, M.D., Ph.D., as Senior Vice President, Clinical Development
-
ACA Foreside Surpasses $500 Billion in ETF Assets Serviced
-
DDC Enterprise Reports Record Earnings for First Half 2025
-
Game On: Topgolf Brings Fun, Food and Play to Avon, Ohio, Friday, Sept. 19
-
BioXcel Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
-
Old Dominion Freight Line Provides Update for Third Quarter 2025
-
ProNexis Partners with Connex AI to Bring Advanced Automation to the Home Services Industry
-
EDEN CEO Ben Phillips to speak at HARDI Focus Conference 2025
-
Two Prime Lending Offers 0% OID Loans for Institutional Bitcoin Holders
-
Bone Biologics CEO Issues Letter to Stockholders Highlighting Company Update and Outlook
-
Hinge Bio Expands Leadership Team to Drive Clinical Development of GEM-DIMER™ Programs and Announces Publication in Scientific Reports
-
New Study Suggests Hydrogen Water May Support Testosterone and Recovery in Male Adults
-
The Future of Agentic Automation Takes Center Stage at ABBYY Ascend Fall October 14, 2025
-
Ketryx Raises $39M Series B Round to Power the Future of Regulated Artificial Intelligence for Life Sciences
-
EmPOWER AI 2025 Conference Unites Energy and AI Innovators Building the Intelligent Grid of the Future
-
Atlas Venture Announces $400 Million Third Opportunity Fund
-
Armata Pharmaceuticals to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
-
Cleveland-Cliffs Reports the Dismissal of Lawsuit by Nippon Steel and U.S. Steel
-
IFF’s Designed Enzymatic Biomaterials™ Platform Sees First Large-Scale Use in Home Care Applications
-
Talitha Koum Partners with Frieze Connect to Spotlight Artist June Lee in Seoul
-
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Merakris Therapeutics Enrolls 30th Subject in Expanded Access Program of MTX-001; Highlights Clinical Progress at SAWC Fall 2025
-
Sol-Gel Announces Health Canada Approval of EPSOLAY®
-
Purple Biotech Announces New Data Supporting the Unique Design of CAPTN-3 Tri-Specific Antibody IM1240 in Collaboration with the Icahn School of Medicine at Mount Sinai
-
Brooge Energy Limited Sets Updated Record Date – Holders must contact brokers to register shares with Continental Stock Transfer & Trust if they are outside the United States and Not U.S. Persons
-
GT Biopharma to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
-
Puro.earth Secures €11 M Series B Financing Led by Nasdaq with Participation from Fortum Innovation & Venturing to strengthen its supplier infrastructure
-
Aduro Clean Technologies to Participate in September Conferences and Initiates Public Relations Campaign
-
Enthusiast Gaming Announces Major Updates to Iconic Addicting Games Platform
-
G-III Apparel Group, Ltd. Reports Second Quarter Fiscal 2026 Results; Provides Updated Fiscal 2026 Outlook
-
Walden Biosciences Announces Key Initiatives to Advance Clinical Pipeline and Support Phase 2 Program for WAL0921 in Rare Kidney Diseases
-
Regenx Provides Bi-Weekly Update on Status of Management Cease Trade Order
-
Helium Evolution Provides Operations Update
-
TappAlpha Expands ETF Lineup with the Innovation 100 Growth & Daily Income ETF (TDAQ)
